Universe Pharmaceuticals INC (UPC)
USD 3.81
(5.54%)
USD 3.81
(5.54%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 5.48 Million USD | 39.28% |
| 2022 | 3.93 Million USD | -9.19% |
| 2021 | 4.33 Million USD | 63.81% |
| 2020 | 2.64 Million USD | 4.93% |
| 2019 | 2.52 Million USD | -3.78% |
| 2018 | 2.62 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 6.5 Million USD | 0.0% |
| 2023 FY | 5.48 Million USD | 39.28% |
| 2023 Q4 | 5.48 Million USD | 0.0% |
| 2023 Q2 | 4.07 Million USD | 0.0% |
| 2022 FY | 3.93 Million USD | -9.19% |
| 2022 Q4 | 3.93 Million USD | 0.0% |
| 2022 Q2 | 4.41 Million USD | 0.0% |
| 2021 Q2 | 2.74 Million USD | 0.0% |
| 2021 FY | 4.33 Million USD | 63.81% |
| 2021 Q4 | 4.33 Million USD | 0.0% |
| 2020 FY | 2.64 Million USD | 4.93% |
| 2020 Q4 | 2.64 Million USD | 0.0% |
| 2020 Q2 | 2.53 Million USD | 0.0% |
| 2019 FY | 2.52 Million USD | -3.78% |
| 2019 Q4 | 2.52 Million USD | 0.0% |
| 2018 FY | 2.62 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Alvotech | 1.07 Billion USD | 99.49% |
| Aquestive Therapeutics, Inc. | 98.82 Million USD | 94.452% |
| Collegium Pharmaceutical, Inc. | 674.28 Million USD | 99.187% |
| Journey Medical Corporation | 17.73 Million USD | 69.078% |
| Dynavax Technologies Corporation | 256.91 Million USD | 97.866% |
| ANI Pharmaceuticals, Inc. | 315.32 Million USD | 98.261% |
| PainReform Ltd. | 86 Thousand USD | -6274.949% |
| Petros Pharmaceuticals, Inc. | 8.27 Million USD | 33.759% |
| Sunshine Biopharma, Inc. | 657.7 Thousand USD | -733.574% |
| Sunshine Biopharma, Inc. | 657.7 Thousand USD | -733.574% |
| SCYNEXIS, Inc. | 15.08 Million USD | 63.644% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| China SXT Pharmaceuticals, Inc. | 2.64 Million USD | -107.084% |
| Esperion Therapeutics, Inc. | 540.94 Million USD | 98.987% |
| Alpha Teknova, Inc. | 30.45 Million USD | 82.0% |
| Pacira BioSciences, Inc. | 586.04 Million USD | 99.064% |
| Intra-Cellular Therapies, Inc. | 16.93 Million USD | 67.632% |
| Bright Green Corporation | 1.85 Million USD | -196.064% |
| Embecta Corp. | 1.63 Billion USD | 99.665% |
| Safety Shot Inc | 1.54 Million USD | -253.941% |
| Procaps Group, S.A. | 285.93 Million USD | 98.083% |
| Cosmos Health Inc. | 12.42 Million USD | 55.872% |
| Theratechnologies Inc. | 58.96 Million USD | 90.703% |
| Harrow Health, Inc. | 190.5 Million USD | 97.122% |
| Sonoma Pharmaceuticals, Inc. | 608 Thousand USD | -801.72% |
| Biofrontera Inc. | 5.39 Million USD | -1.546% |
| DURECT Corporation | 20.74 Million USD | 73.573% |
| Supernus Pharmaceuticals, Inc. | 41.52 Million USD | 86.798% |
| Cronos Group Inc. | 2.53 Million USD | -115.85% |
| OptiNose, Inc. | 131.74 Million USD | 95.839% |
| Ironwood Pharmaceuticals, Inc. | 715.53 Million USD | 99.234% |
| Kala Pharmaceuticals, Inc. | 36.32 Million USD | 84.906% |
| RedHill Biopharma Ltd. | 1.17 Million USD | -367.385% |
| Organogenesis Holdings Inc. | 119.35 Million USD | 95.406% |
| Guardion Health Sciences, Inc. | - USD | -Infinity% |
| Cumberland Pharmaceuticals Inc. | 18.42 Million USD | 70.25% |
| Radius Health, Inc. | 365.31 Million USD | 98.499% |
| ProPhase Labs, Inc. | 21.38 Million USD | 74.357% |
| Phibro Animal Health Corporation | 525.45 Million USD | 98.957% |
| Procaps Group S.A. | 285.93 Million USD | 98.083% |
| TherapeuticsMD, Inc. | 8 Million USD | 31.512% |
| Viatris Inc. | 18.12 Billion USD | 99.97% |
| Rockwell Medical, Inc. | 13.43 Million USD | 59.205% |
| Aytu BioPharma, Inc. | 15.12 Million USD | 63.762% |
| SIGA Technologies, Inc. | 1.46 Million USD | -274.482% |
| Tilray Brands, Inc. | 387.31 Million USD | 98.585% |
| Lifecore Biomedical, Inc. | 130.36 Million USD | 95.794% |
| Shineco, Inc. | 29.65 Million USD | 81.513% |
| PetIQ, Inc. | 468.3 Million USD | 98.829% |
| Regencell Bioscience Holdings Limited | 59.8 Thousand USD | -9066.914% |
| Incannex Healthcare Limited | 373 Thousand USD | -1369.827% |
| Neurocrine Biosciences, Inc. | 428.4 Million USD | 98.72% |
| Alimera Sciences, Inc. | 67.39 Million USD | 91.866% |
| Assertio Holdings, Inc. | 40.91 Million USD | 86.599% |
| Shuttle Pharmaceuticals Holdings, Inc. | 1.08 Million USD | -404.044% |
| Clever Leaves Holdings Inc. | 2.08 Million USD | -162.696% |
| Cyclo Therapeutics, Inc. | 1.03 Million USD | -430.672% |
| Avadel Pharmaceuticals plc | 35.38 Million USD | 84.506% |
| Hempacco Co., Inc. | 13.72 Million USD | 60.054% |
| Talphera, Inc. | - USD | -Infinity% |
| Alvotech | 1.07 Billion USD | 99.49% |
| Eagle Pharmaceuticals, Inc. | 62.46 Million USD | 91.223% |
| Lantheus Holdings, Inc. | 616.94 Million USD | 99.111% |
| Currenc Group, Inc. | 31.94 Million USD | 82.837% |
| Kamada Ltd. | 8.74 Million USD | 37.336% |
| Indivior PLC | 281.6 Million USD | 98.053% |
| Evoke Pharma, Inc. | 5 Million USD | -9.649% |
| Flora Growth Corp. | 3.67 Million USD | -49.304% |
| Cyclo Therapeutics, Inc. | 1.03 Million USD | -430.672% |
| Evolus, Inc. | 126.54 Million USD | 95.668% |
| HUTCHMED (China) Limited | 86.13 Million USD | 93.635% |
| Amphastar Pharmaceuticals, Inc. | 623.64 Million USD | 99.121% |
| Akanda Corp. | 3.99 Million USD | -37.103% |